Addiction Medicine
News
FDA OKs higher-dose naloxone nasal spray for opioid overdose
Kloxxado delivers 8 mg of naloxone into the nasal cavity, which is twice as much as the 4 mg of naloxone contained in Narcan.
News
The cloudy role of cannabis as a neuropsychiatric treatment
Medical cannabis has been made widely available to patients and has largely outpaced the clinical evidence.
News
Doctors more likely to prescribe opioids to COVID ‘long-haulers,’ raising addiction fears
The new study “suggests to me that many clinicians still don’t get it,” said Dr. Andrew Kolodny.
Commentary
How physicians can provide better care to transgender patients
Those transgender patients who seek care often have unpleasant experiences.
What's Your Diagnosis?
Gastrointestinal Symptoms and Lactic Acidosis in a Chronic Marijuana User
A patient presented with diffuse abdominal pain and a history of frequent cannabis use, a diet lacking in meat and fish, and an increase in...
News
Black nonsmokers still at high risk for secondhand smoke exposure
The prevalence of SHS exposure among nonsmokers declined from 87.5% to 25.3% between 1988 and 2012.
News
THC persists in breast milk 6 weeks after quitting cannabis
Detectable levels of THC suggest any use is of concern and no safety thresholds have been established.
News
Buprenorphine for OUD may also mitigate risk with concomitant benzo, Z-drug use
“It seems like the individuals with polysubstance use are largely ignored in the setting of the opioid epidemic,” said Dr. Kevin Xu.
News
Fauci worries about possible post–COVID-19 ‘mental health pandemic’
“I hope we don’t see an increase in some preventable situations that would not have happened if people had the normal access to medical care,”...
News
Vaccine may blunt effects of deadly synthetic opioids
The latest data bring “hope that this approach will work to treat a number of opioid-related maladies,” said Dr. Kim Janda.